1. Home
  2. ANNX vs KLTR Comparison

ANNX vs KLTR Comparison

Compare ANNX & KLTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANNX
  • KLTR
  • Stock Information
  • Founded
  • ANNX 2011
  • KLTR 2006
  • Country
  • ANNX United States
  • KLTR United States
  • Employees
  • ANNX N/A
  • KLTR N/A
  • Industry
  • ANNX Biotechnology: Pharmaceutical Preparations
  • KLTR EDP Services
  • Sector
  • ANNX Health Care
  • KLTR Technology
  • Exchange
  • ANNX Nasdaq
  • KLTR Nasdaq
  • Market Cap
  • ANNX 334.1M
  • KLTR 302.6M
  • IPO Year
  • ANNX 2020
  • KLTR 2021
  • Fundamental
  • Price
  • ANNX $3.00
  • KLTR $1.61
  • Analyst Decision
  • ANNX Strong Buy
  • KLTR Buy
  • Analyst Count
  • ANNX 4
  • KLTR 3
  • Target Price
  • ANNX $13.00
  • KLTR $2.83
  • AVG Volume (30 Days)
  • ANNX 2.1M
  • KLTR 260.7K
  • Earning Date
  • ANNX 11-13-2025
  • KLTR 11-07-2025
  • Dividend Yield
  • ANNX N/A
  • KLTR N/A
  • EPS Growth
  • ANNX N/A
  • KLTR N/A
  • EPS
  • ANNX N/A
  • KLTR N/A
  • Revenue
  • ANNX N/A
  • KLTR $181,350,000.00
  • Revenue This Year
  • ANNX N/A
  • KLTR $3.49
  • Revenue Next Year
  • ANNX N/A
  • KLTR $3.02
  • P/E Ratio
  • ANNX N/A
  • KLTR N/A
  • Revenue Growth
  • ANNX N/A
  • KLTR 2.56
  • 52 Week Low
  • ANNX $1.29
  • KLTR $1.27
  • 52 Week High
  • ANNX $7.74
  • KLTR $2.82
  • Technical
  • Relative Strength Index (RSI)
  • ANNX 51.42
  • KLTR 54.69
  • Support Level
  • ANNX $2.87
  • KLTR $1.46
  • Resistance Level
  • ANNX $3.36
  • KLTR $1.71
  • Average True Range (ATR)
  • ANNX 0.21
  • KLTR 0.10
  • MACD
  • ANNX -0.03
  • KLTR 0.01
  • Stochastic Oscillator
  • ANNX 25.24
  • KLTR 63.04

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.

About KLTR Kaltura Inc.

Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.

Share on Social Networks: